Satellite Pharmaceuticals Private Limited

Satellite Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24319MH1994PTC079317 Incorporated 30 June 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹1.74 Cr
▲ 18% YoY
Net loss · FY 2025
₹60.04 Lakh
Net margin -34.5%
EBITDA · FY 2025
-₹10.58 Lakh
EBITDA margin -6.1%
Authorised capital
₹2.65 Cr
Registered with MCA
Paid-up capital
₹2.65 Cr
Issued & subscribed
Open charges
₹4.8 Cr
Satisfied ₹3.08 Cr
Company age
32 yrs
Est. 1994
Directors on board
3
As per MCA filings

About Satellite Pharmaceuticals Private Limited

Data last updated:

Satellite Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24319MH1994PTC079317. Its GSTIN is 27AAGCS7317D1ZE (Maharashtra).

The company has an authorised share capital of ₹2.65 Cr and a paid-up capital of ₹2.65 Cr. It is led by directors including Bhharat Kantilal Parekh (Managing Director) and Vijay Ambadasrao Kadam.

Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.74 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹60.04 Lakh (net margin -34.5%) and EBITDA of -₹10.58 Lakh (EBITDA margin -6.1%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 11% over five years.

As per MCA filings, the company has open charges of ₹4.8 Cr and satisfied charges of ₹3.08 Cr on record. Court records list 12 cases involving the company, including 6 filed by the company and 6 filed against it; 2 cases are pending.

Satellite Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0067668). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24319MH1994PTC079317
Registration Number 079317
Incorporation Date 30 June 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0067668
Key People
Bhharat Kantilal Parekh Managing Director Vijay Ambadasrao Kadam Director Dolly Bharat Parekh Director

Recognitions & Rankings of Satellite Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-19-0067668

Contact details

Satellite Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Gala No 108 1 Floor Parekh Prints Building Itt Bhatti Goregaon – Mulund Link Road G, Oregaon (E, Mumbai, Maharashtra, India – 400063
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Satellite Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Satellite Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Satellite Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Satellite Pharmaceuticals Private Limited, buy the company report.

Financials of Satellite Pharmaceuticals Private Limited

FY 2025 filings available

Satellite Pharmaceuticals Private Limited reported revenue of ₹1.74 Cr (up 18% YoY) for FY 2025.

Revenue · FY 2025
₹1.74 Cr ▲ 18%
Net loss · FY 2025
₹60.04 Lakh margin -34.5%
EBITDA · FY 2025
-₹10.58 Lakh margin -6.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 28%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 29%
5 years · compounded
▼ 17%

Revenue rose 18% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹10.58 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹60.04 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-6.1%
Net Profit Margin-34.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Satellite Pharmaceuticals Private Limited, buy the company report.

Board of directors of Satellite Pharmaceuticals Private Limited

Satellite Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhharat Kantilal Parekh
Also directs: Parekh Pharma Chem LLP
Managing Director26 Sep 20188 Years 1 MonthsCurrent
Vijay Ambadasrao Kadam
Also directs: Nirvikalpa Pharmachem Private Limited
Director21 May 20215 Years 5 MonthsCurrent
Dolly Bharat Parekh
Also directs: Parekh Pharma Chem LLP, Durga Estate Agency LLP
Director21 May 20215 Years 5 MonthsCurrent
View all directors

Peer comparison

Satellite Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Universal Drug House Pvt Ltd₹1.75 Cr (FY 2025)-3.0%Beleghata, West Bengal, India
Ultracare Remedies Private Limited₹1.75 Cr (FY 2025)-16.0%Rajkot, Gujarat, India
Satellite Pharmaceuticals Private Limitedthis company₹1.74 Cr (FY 2025)-₹60.04 Lakh-34.5%18.0%Mumbai, Maharashtra, India
Adam Laboratories Private Limited₹1.74 Cr (FY 2024)17.0%Uttar Pradesh, India

To see the full peer comparison of Satellite Pharmaceuticals Private Limited, buy the company report.

Auditor

Satellite Pharmaceuticals Private Limited is audited by RHB & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RHB & AssociatesFY 2023144667W

Shareholding

The shareholding of Satellite Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Satellite Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.8 Cr
Satisfied charges
₹3.08 Cr
Breakdown by lending institutions
Others₹4.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Jan 2020100324410Others₹1 CrOpen
18 Dec 2018100239125Others₹3.1 CrOpen
26 Mar 2018100169490Others₹50 LakhOpen
04 Dec 201310465101Others₹20 LakhOpen
25 Aug 200710071556Bank of Baroda₹1.34 CrSatisfied

To see the full charge records of Satellite Pharmaceuticals Private Limited, buy the company report.

Total charge records: 10 View all charges

MSME payment delays

Satellite Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2022 and 2023, listing 71 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 13)

SupplierAmount dueDue sinceReported on
Ullmann Laboratories Private Limited
New Bombay Engineering Co.
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Satellite Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Satellite Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCS7317D1ZEMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Satellite Pharmaceuticals Private Limited, buy the company report.

Recent activity

Satellite Pharmaceuticals Private Limited has 12 board changes on record since 2016: 3 appointments and 9 cessations. The latest: Dolly Bharat Parekh ceased to be Director on 29 Nov 2021.

AGM
Satellite Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Satellite Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Dolly Bharat Parekh ceased to be Director.
Ceased
Vijay Ambadasrao Kadam ceased to be Director.
Ceased
Tukaram Baliramrao Kulkarni ceased to be Director.
Appointed
Dolly Bharat Parekh was appointed as Director.
Appointed
Vijay Ambadasrao Kadam was appointed as Director.
Ceased
Jitesh Premjibhai Hinhoriya ceased to be Director.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100324410 was registered on 24 Jan 2020.
Charges
A charge with Others of Rs. 3.10 Cr registered on 18 Dec 2018 with Charge ID 100239125 was modified on 06 May 2019.
Charges
A charge with Others amounted to Rs. 3.10 Cr with Charge ID 100239125 was registered on 18 Dec 2018.
Appointed
Bhharat Kantilal Parekh was appointed as Managing Director.

22 earlier events are in the company report.

Frequently asked questions

Satellite Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 1994 (32+ years old) and is registered under CIN U24319MH1994PTC079317.

Satellite Pharmaceuticals has 3 current directors:

The latest financial statements of Satellite Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Satellite Pharmaceuticals is 27AAGCS7317D1ZE, registered in Maharashtra.

The CIN (Corporate Identification Number) of Satellite Pharmaceuticals is U24319MH1994PTC079317. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Satellite Pharmaceuticals has 12 court cases on record: 6 filed by the company and 6 filed against it. 2 are pending. Most are in the district courts.

Satellite Pharmaceuticals was incorporated on 30 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Satellite Pharmaceuticals by revenue are Universal Drug House Pvt Ltd, Ultracare Remedies Private Limited, Adam Laboratories Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dolly Bharat Parekh ceased to be Director on 29 Nov 2021. Vijay Ambadasrao Kadam ceased to be Director on 29 Nov 2021. Tukaram Baliramrao Kulkarni ceased to be Director on 02 Jun 2021. Satellite Pharmaceuticals has 12 board changes on record in total.

Yes, Satellite Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0067668).

Satellite Pharmaceuticals has 4 MSME Form 1 returns on record between 2022 and 2023, listing 71 overdue payments to 13 micro and small suppliers. The latest return was filed on 29 Aug 2023.

The registered office of Satellite Pharmaceuticals is at Gala No 108 1 Floor Parekh Prints Building Itt Bhatti Goregaon – Mulund Link Road G, Oregaon E, Mumbai, Maharashtra, India – 400063.